A Multi-Center, Randomised, Double-Blind, Placebo-Controlled Phase III Clinical Trial Evaluating the Impact of BCG Re-Vaccination on the Incidence and Severity of SARS-CoV-2 Infections among Symptomatic Healthcare Professionals during the COVID-19 Pandemic in Poland—First Results

Tuberculosis vaccines (Bacillus Calmette-Guérin, BCG) were introduced 100 years ago and are still recommended by the World Health Organization to prevent the disease. Studies have shown that BCG vaccination can stimulate non-specific immune responses and reduce the incidence of certain diseases. At...

Descripción completa

Detalles Bibliográficos
Autores principales: Czajka, Hanna, Zapolnik, Paweł, Krzych, Łukasz, Kmiecik, Wojciech, Stopyra, Lidia, Nowakowska, Anna, Jackowska, Teresa, Darmochwał-Kolarz, Dorota, Szymański, Henryk, Radziewicz-Winnicki, Igor, Mazur, Artur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8879775/
https://www.ncbi.nlm.nih.gov/pubmed/35214772
http://dx.doi.org/10.3390/vaccines10020314

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8879775/
https://www.ncbi.nlm.nih.gov/pubmed/35214772
http://dx.doi.org/10.3390/vaccines10020314

Ejemplares similares